Key facts
- WRF Capital is a other based in Seattle, Washington with 21 tracked portfolio companies.
- Notable positions include Xaira Therapeutics, Group14 Technologies, Umoja Biopharma, Tune Therapeutics, Outpace Bio.
About WRF Capital
WRF Capital is a direct investment firm based in Seattle, Washington. Established in 1981, it is the investment vehicle for the Washington Research Foundation that works with entrepreneurs, research institutions, other investors, and industry partners to transform great ideas into successful Washington-based businesses. The assets of the firm are managed by the executive management team.
Free account
See the whole book
- ·The book's top 25 — of 21 recorded positions
- ·Watchlist + alerts for WRF Capital's activity
Create free account
No card required
Portfolio, priced
21 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Xaira Therapeutics | Biotech | $3.5B | — | |
| Group14 Technologies | Other Materials | $3.3B | — | |
| Umoja Biopharma | — | $420.0M | — | |
| Tune Therapeutics | — | $340.0M | — | |
| Outpace Bio | Discovery Tools (Healthcare) | $220.0M | — | |
| Arzeda | — | $149.5M | — | |
| Vilya | — | $144.0M | — | |
| HyperSciences | — | $104.4M | — | |
| Cyrus Biotechnology | — | $45.5M | — | |
| AdaptX | — | $40.0M | — | |
| Talus Bio | — | $31.2M | — | |
| Membrion | — | $27.5M | — | |
| Mpathic | — | $26.0M | — | |
| Watershed Therapeutics | — | $24.9M | — | |
| Accipiter Biosciences | — | $22.0M | — | |
| + 6 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does WRF Capital invest in?
- WRF Capital has 21 recorded portfolio companies, including Xaira Therapeutics, Group14 Technologies, Umoja Biopharma, Tune Therapeutics.